Mouse Anti-OGA Recombinant Antibody (A1080) (CBMAB-AP11813LY)

Pagesy, P., Bouaboud, A., Feng, Z., Hulin, P., & Issad, T. (2022). Short O-GlcNAcase is targeted to the mitochondria and regulates mitochondrial reactive oxygen species level. Cells, 11(11), 1827.

Muha, V., Authier, F., Szoke-Kovacs, Z., Johnson, S., Gallagher, J., McNeilly, A., ... & van Aalten, D. M. (2021). Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis. Journal of Biological Chemistry, 296.

Bartolomé-Nebreda, J. M., Trabanco, A. A., Velter, A. I., & Buijnsters, P. (2021). O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer’s disease and related tauopathies: analysis of the patent literature. Expert opinion on therapeutic patents, 31(12), 1117-1154.

Stephen, H. M., Adams, T. M., & Wells, L. (2021). Regulating the regulators: mechanisms of substrate selection of the O-GlcNAc cycling enzymes OGT and OGA. Glycobiology, 31(7), 724-733.

Kositzke, A., Fan, D., Wang, A., Li, H., Worth, M., & Jiang, J. (2021). Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe. International journal of biological macromolecules, 169, 51-59.

Elbatrawy, A. A., Kim, E. J., & Nam, G. (2020). O‐GlcNAcase: emerging mechanism, substrate recognition and small‐molecule inhibitors. ChemMedChem, 15(14), 1244-1257.

Martínez-Viturro, C. M., Trabanco, A. A., Royes, J., Fernández, E., Tresadern, G., Vega, J. A., ... & Bartolomé-Nebreda, J. M. (2020). Diazaspirononane nonsaccharide inhibitors of O-GlcNAcase (OGA) for the treatment of neurodegenerative disorders. Journal of medicinal chemistry, 63(22), 14017-14044.

Muha, V., Fenckova, M., Ferenbach, A. T., Catinozzi, M., Eidhof, I., Storkebaum, E., ... & van Aalten, D. M. (2020). O-GlcNAcase contributes to cognitive function in Drosophila. Journal of Biological Chemistry, 295(26), 8636-8646.

Singh, J. P., Qian, K., Lee, J. S., Zhou, J., Han, X., Zhang, B., ... & Yang, X. (2020). O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth. Oncogene, 39(3), 560-573.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols